Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03533777 · ClinicalTrials.gov registry record · NA
Antegrade Versus Retrograde IV for Blood Draws
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT03533777 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 230 participants.
The verdict
NCT03533777, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
The purpose of this study is to compare success rates of antegrade and retrograde intravenous (IV) catheters in their ability to aspirate 20 milliliter blood sample within a 2 minute time frame, 3 hours after initial insertion. Antegrade IV catheters are placed identically to conventional IV catheters, with the end of the catheter pointed toward the direction of blood flow to the heart. Retrograde catheters are placed "backwards" with the end of the catheter pointed away from the direction of venous blood flow. The hypothesis is that retrograde IVs will have a significantly higher success rate of blood draw at the 3 hour time mark without use of a proximal tourniquet.
Interventions
- OTHER Blood draw
- PROCEDURE Peripheral intravenous catheter placement
- DEVICE Peripheral intravenous catheter
- DRUG To keep open (TKO) infusion of 0.9% normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2018-06-22 |
| Est. Completion | 2019-06-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03533777
The ClinicalTrials.gov registry entry for NCT03533777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Blood draw is the first listed.
NCT03533777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03533777 about?
NCT03533777 is a clinical study titled "Antegrade Versus Retrograde IV for Blood Draws". The purpose of this study is to compare success rates of antegrade and retrograde intravenous (IV) catheters in their ability to aspirate 20 milliliter blood sample within a 2 minute time frame, 3 hours after initial insertion. Antegrade IV catheters are placed identically to conventional IV cathete...
What is the current status of trial NCT03533777?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2018-06-22. Estimated completion is 2019-06-19.
What interventions are being tested in trial NCT03533777?
The interventions under investigation include: Blood draw (OTHER), Peripheral intravenous catheter placement (PROCEDURE), Peripheral intravenous catheter (DEVICE), To keep open (TKO) infusion of 0.9% normal saline (DRUG).
Who is sponsoring clinical trial NCT03533777?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.